Patients' Attitudes Toward and Experiences With Buprenorphine Treatment

Paused

Conditions studied: Opioid-use Disorder, Acceptability of Health Care, Opioid-Related Disorders

In brief

This study will disseminate five surveys collecting individual's attitudes and experiences during buprenorphine treatment for Opioid Use Disorder during the COVID-19 pandemic.

Key facts

Study ID

NCT05121428

Run by

Cambridge Health Alliance

People needed

817

Starts

2021-11-20

Expected to finish

2027-03-20

Last updated by the study team

2025-07-11

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Participants must be 18 years of age or older.
• Participants report currently having a legal prescription for buprenorphine for opioid use disorder.
• Participants must have a past or present opioid use disorder.
• Participants must currently reside in the state of Massachusetts.
• Participants must be able to comprehend the English language.

You may not qualify if…

• Unable to complete an online survey.
• Unable to complete a verification step that ensures bots are not used to complete survey.
• Complete a survey with no variation suggesting they did not read the survey.

Where it is running

• CHA Center for Mindfulness and Compassion — Cambridge, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.